Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01997450 · ClinicalTrials.gov registry record

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

A clinical trial, sponsored by MedImmune.

Terminated
Registry status
4,121
Enrollment target

NCT01997450 is a clinical trial that was terminated before completion, run by MedImmune. The registered enrollment target is 4,121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01997450 was terminated before completion, sponsored by MedImmune.

TERMINATED
Registry status
4,121 participants
Enrollment target

Study Summary

This is a post-marketing case-controlled study of the effectiveness of a quadrivalent live attenuated influenza vaccine (Q/LAIV/FluMist® Quadrivalent) versus Inactivated Influenza Vaccine (IIV) and No Vaccine in subjects 2-17 years of age.

Trial Details

FieldValue
Enrollment Target 4,121 participants
Start Date 2013-12-02
Est. Completion 2016-04-15

Sponsor

MedImmune

210 total trials

What the Registry Record Tells You About NCT01997450

The ClinicalTrials.gov registry entry for NCT01997450 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4,121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01997450 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01997450 about?

NCT01997450 is a clinical study titled "A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age". This is a post-marketing case-controlled study of the effectiveness of a quadrivalent live attenuated influenza vaccine (Q/LAIV/FluMist® Quadrivalent) versus Inactivated Influenza Vaccine (IIV) and No Vaccine in subjects 2-17 years of age.

What is the current status of trial NCT01997450?

This trial is currently terminated. The enrollment target is 4,121 participants. The study started on 2013-12-02. Estimated completion is 2016-04-15.

Who is sponsoring clinical trial NCT01997450?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.